Charles River Labs upgraded to Overweight from Neutral at JPMorgan JPMorgan upgraded Charles River Labs citing a favorable risk/reward following yesterday's sell-off. The firm expects the company's fundamentals to improve in 2013 and raised its price target for shares to $42 from $40. Note Charles River Labs shares were also upgraded this morning at Wells Fargo.
News For CRL From The Last 14 Days
Check below for free stories on CRL the last two weeks.